Recently performed uncontrolled research suggested that MBCT is an effective treatment for anxiety disorders on short-term, but the long-term effects aren*t investigated yet. This study wants to examine this question by comparing a group of clients…
ID
Source
Brief title
Condition
- Anxiety disorders and symptoms
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The participants shall be asked to fill in four questionnaires:
1. The *Symptom Checklist 90* (SCL-90):
The questionnaire measures the amount of physical and psychological complaints
the person had during the past week (90 items).
2. The *Positive Outcome Scale* (PUL):
The questionnaire measures the positive, on ability to bear related
characteristic features of the participants (10 items).
3. The *Mindful Attention Awareness Scale* (MAAS):
The questionnaire measures the amount of attention and concentration/amount of
*mindfulness* of the participants (15 items).
4. Additional questions are formulated regarding current medicine use, current
treatment, life events, psychological complaints, physical complaints, the
effectiveness of MBCT and the current use of MBCT-techniques (10 items).
Secondary outcome
-
Background summary
Mindfulness Based Cognitive Therapy (MBCT) is developed by Segal, Williams and
Teasdale and based on Buddhist principles. Mindfulness is de concept of
focusing your attention consciously towards something, in which you stay in the
present time and don*t judge about what you perceive. In MBCT clients learn to
accept their negative thoughts and emotions. The therapy form consists of 8
weekly meetings with training programs such as meditation and breathing
exercises. Research concluded that MBCT is an effective treatment for relapse
prevention in depression. Uncontrolled researches showed that MBCT is effective
for clients who don*t are don*t fully respond to usual treatments (cognitive
behavioral therapy and/or medication). This is the reason why MBCT is offered
to (treatment-resistant) anxiety clients at the department of anxiety disorders
(PsyQ) since 2006.
Study objective
Recently performed uncontrolled research suggested that MBCT is an effective
treatment for anxiety disorders on short-term, but the long-term effects aren*t
investigated yet. This study wants to examine this question by comparing a
group of clients who have received MBCT with a group of clients who haven*t
received this treatment. With this research we hope to deliver a contribution
to the amount of *evidence-based* treatments that are offered at PsyQ.
Study design
In order to perform this research, two groups shall be compared: a group of
clients who have received that MBCT-treatment 1,5 years ago (after the usual
treatments) and a control group in which the clients only received that usual
treatments (and not the MBCT). The control group will be matched to the
MBCT-group on the following factors: DSM-IV diagnosis, SCL-90 score, age,
gender and treatment history. All participants are currently in an after-care
group at PsyQ, anxiety disorders. Both groups will be asked to fill in four
questionnaires (one visit of approximately 30 minutes). These questionnaires
will be compared with questionnaires that were filled in earlier (after
treatment disclosure at PsyQ).
Study burden and risks
There will be no risks for the participants in this research.
Stadhoudersplantsoen 2
2517 JL Den Haag
Nederland
Stadhoudersplantsoen 2
2517 JL Den Haag
Nederland
Listed location countries
Age
Inclusion criteria
1. Diagnosed with an anxiety disorder.
2. Having received treatment for this disorder at PsyQ.
3. Fluency in the Dutch language.
Exclusion criteria
1. Currently receiving active treatment (for the same anxiety complaint that was treated at PsyQ). Medication is allowed.
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL21834.097.08 |